Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 8, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jacob Hughes Downgraded (AMPH) to Hold and Held Target at $21 on, Jan 8th, 2021
Jacob Hughes of Wells Fargo, Downgraded "Amphastar Pharmaceuticals, Inc." (AMPH) to Hold and Held Target at $21 on, Jan 8th, 2021.
Jacob has made no other calls on AMPH in the last 4 months.
There is 1 other peer that has a rating on AMPH. Out of the 1 peers that are also analyzing AMPH, 0 agree with Jacob's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jacob
- Timothy Chiang of "Northland Capital Markets" Upgraded from Hold to Buy on, Monday, October 5th, 2020
